Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($) $ in Thousands	Convertible Series A Preferred Shares	Convertible Series B Preferred Shares	Convertible Series C Preferred Shares	Series F Preferred Shares	Common Shares	Additional Paid-in Capital	Accumulated Deficit	Other Comprehensive Income	Stockholders’ Deficit	Noncontrolling Interest	Total
Balance at Jul. 31, 2020					$ 101	$ 86,364	$ (88,697)	$ 1	$ (2,231)	$ (382)	$ (2,613)
Balance (in Shares) at Jul. 31, 2020	225,000	407,477		100	101,323,590
Amortization of employee stock options						20			20		20
Common stock issued for services, to employees					$ 8	257			265		265
Common stock issued for services, to employees (in Shares)					7,858,820
Common stock issued for services					$ 2	56			58		58
Common stock issued for services (in Shares)					2,000,000
Common stock issued for debt conversion					$ 10	147			157		157
Common stock issued for debt conversion (in Shares)					10,000,000
Common stock issued concurrent with convertible debt					$ 1	44			45		45
Common stock issued concurrent with convertible debt (in Shares)					1,000,000
Beneficial conversion feature on convertible debt						111			111		111
Derivative liability resolved to APIC due to note conversion						205			205		205
Dividends declared						(5)			(5)		(5)
Net income (loss)							(721)		(721)	(35)	(756)
Balance at Oct. 31, 2020					$ 122	87,199	(89,418)	1	(2,096)	(417)	(2,513)
Balance (in Shares) at Oct. 31, 2020	225,000	407,477		100	122,182,410
Amortization of employee stock options						33			33		33
Common stock issued for settlement of accounts payable					$ 1	59			60		60
Common stock issued for settlement of accounts payable (in Shares)					1,000,000
Common stock issued for debt conversion					$ 11	243			254		254
Common stock issued for debt conversion (in Shares)					10,676,765
Common stock issued concurrent with convertible debt						24			24		24
Common stock issued concurrent with convertible debt (in Shares)					500,000
Beneficial conversion feature on convertible debt						30			30		30
Derivative liability resolved to APIC due to note conversion						383			383		383
Dividends declared						(5)			(5)		(5)
Net income (loss)							(1,950)		(1,950)	(30)	(1,980)
Balance at Jan. 31, 2021					$ 134	87,966	(91,368)	1	(3,267)	(447)	(3,714)
Balance (in Shares) at Jan. 31, 2021	225,000	407,477		100	134,359,175
Amortization of employee stock options						57			57		57
Preferred Stock Series B issued for debt settlement						18			18		18
Preferred Stock Series B issued for debt settlement (in Shares)		17,965
Preferred Stock Series C issued for debt settlement						554			554		554
Preferred Stock Series C issued for debt settlement (in Shares)			55,400
Common stock issued for services					$ 2	123			125		125
Common stock issued for services (in Shares)					2,000,000
Common stock issued for exercise of warrants						30			30		30
Common stock issued for exercise of warrants (in Shares)					300,000
Common stock issued for debt conversion					$ 1	17			18		18
Common stock issued for debt conversion (in Shares)					598,825
Common stock issued concurrent with convertible debt					$ 1	77			78		78
Common stock issued concurrent with convertible debt (in Shares)					600,000
Beneficial conversion feature on convertible debt						413			413		413
Dividends declared						(5)			(5)		(5)
Net income (loss)							(12,798)		(12,798)	(158)	(12,956)
Balance at Apr. 30, 2021					$ 138	89,250	(104,166)	1	(14,777)	(605)	(15,382)
Balance (in Shares) at Apr. 30, 2021	225,000	425,442	55,400	100	137,858,000
Balance at Jul. 31, 2021					$ 139	89,100	(105,380)	1	(16,140)	(714)	(16,854)
Balance (in Shares) at Jul. 31, 2021	225,000	425,442	55,400	100	138,538,039
Amortization of employee stock options						24			24		24
Common stock issued concurrent with convertible debt						38			38		38
Common stock issued concurrent with convertible debt (in Shares)					600,000
Dividends declared						(5)			(5)		(5)
Net income (loss)							2,424		2,424	(158)	2,266
Balance at Oct. 31, 2021					$ 139	89,157	(102,956)	1	(13,659)	(872)	(14,531)
Balance (in Shares) at Oct. 31, 2021	225,000	425,442	55,400	100	139,138,039
Amortization of employee stock options						23			23		23
Common stock issued concurrent with convertible debt
Common stock issued concurrent with convertible debt (in Shares)					600,000
Dividends declared						(5)			(5)		(5)
Net income (loss)							(11,042)		(11,042)	(602)	(11,644)
Balance at Jan. 31, 2022					$ 139	89,175	(113,998)	1	(24,683)	(1,474)	(26,157)
Balance (in Shares) at Jan. 31, 2022	225,000	425,442	55,400	100	139,738,039
Amortization of employee stock options						28			28		28
Common stock issued for debt extension						34			34		34
Common stock issued for debt extension (in Shares)					250,000
Derivative liability resolved to APIC due to note payoff						76			76		76
Dividends declared						(4)			(4)		(4)
Net income (loss)							3,906		3,906	(546)	3,360
Balance at Apr. 30, 2022					$ 139	$ 89,309	$ (110,092)	$ 1	$ (20,643)	$ (2,020)	$ (22,663)
Balance (in Shares) at Apr. 30, 2022	225,000	425,442	55,400	100	139,988,039